Join

Compare · FLXN vs MNLO

FLXN vs MNLO

Side-by-side comparison of Flexion Therapeutics, Inc. (FLXN) and Menlo Therapeutics Inc. (MNLO): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both FLXN and MNLO operate in Major Pharmaceuticals (Health Care), so they compete in similar markets.
  • FLXN carries a market cap of $458.9M.
  • FLXN has more recent analyst coverage (7 ratings vs 0 for MNLO).
MetricFLXNMNLO
Company
Flexion Therapeutics, Inc.
Menlo Therapeutics Inc.
Price
-
-
Market cap
$458.9M
-
1M return
+2.03%
-
1Y return
+0.35%
-
Industry
Major Pharmaceuticals
Major Pharmaceuticals
Exchange
NASDAQ
NASDAQ
IPO
2014
2018
News (4w)
0
0
Recent ratings
7
0
FLXN

Flexion Therapeutics, Inc.

Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions in the United States. The company offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) knee pain. It is also involved in the development of FX201, a gene therapy product candidate designed to provide on demand production of an anti-inflammatory protein, interleukin-1 receptor antagonist for pain relief from OA of the knee; and FX301, a NaV1.7 inhibitor for the management of post-operative pain. The company was founded in 2007 and is headquartered in Burlington, Massachusetts.